EU approves upscaling of Moderna vaccine in US production facilities
The EMA CHMP has given the stamp of approval for US medical company Moderna to increase its production of the active substance in the firm's coronavirus vaccine in two of the company's US facilities.
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY NIELSINE NIELSEN
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has given the green light for the US pharmaceutical company Moderna to increase the production of the active substance in the firm's covid-19 vaccine known as Spikevax in two of the firm's factories on US soil.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Pfizer and Moderna raise prices for coronavirus vaccines
For subscribers
.jpg)
.jpg&w=384&q=75)
